The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo

Abstract Christensenellaceae is a family of subdominant commensal bacteria found in humans. It is thought to play an important role in gut health by maintaining microbial symbiosis. Indeed, these bacteria occur at significantly lower levels or are absent in individuals suffering from inflammatory bo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Camille Kropp, Katy Le Corf, Karima Relizani, Kevin Tambosco, Ccori Martinez, Florian Chain, Georges Rawadi, Philippe Langella, Sandrine P. Claus, Rebeca Martin
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9f0a79730e0d456f87c210b29cb9337f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f0a79730e0d456f87c210b29cb9337f
record_format dspace
spelling oai:doaj.org-article:9f0a79730e0d456f87c210b29cb9337f2021-12-02T15:02:57ZThe Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo10.1038/s41598-021-90885-12045-2322https://doaj.org/article/9f0a79730e0d456f87c210b29cb9337f2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90885-1https://doaj.org/toc/2045-2322Abstract Christensenellaceae is a family of subdominant commensal bacteria found in humans. It is thought to play an important role in gut health by maintaining microbial symbiosis. Indeed, these bacteria occur at significantly lower levels or are absent in individuals suffering from inflammatory bowel diseases (IBDs). Here, we explored if type species Christensenella minuta (strain: DSM 22607) could have the potential to help treat IBDs. We assessed key properties displayed by the bacterium using a combination of in vitro and in vivo assays. We found that while C. minuta is a strict anaerobe, it is also oxygen tolerant. Additionally, we observed that the species produces high levels of acetate and moderate levels of butyrate. We performed deep phenotyping using Biolog microarrays. Using human intestinal cell lines, we discovered that C. minuta demonstrated strong anti-inflammatory activity, resulting in reduced levels of proinflammatory IL-8 cytokines via the inhibition of the NF-κB signaling pathway. Furthermore, C. minuta protected intestinal epithelial integrity in vitro. Finally, in two distinct animal models of acute colitis, C. minuta prevented intestinal damage, reduced colonic inflammation, and promoted mucosal healing. Together, these results indicate that C. minuta has potent immunomodulatory properties, underscoring its potential use in innovative microbiome-based IBD biotherapies.Camille KroppKaty Le CorfKarima RelizaniKevin TamboscoCcori MartinezFlorian ChainGeorges RawadiPhilippe LangellaSandrine P. ClausRebeca MartinNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Camille Kropp
Katy Le Corf
Karima Relizani
Kevin Tambosco
Ccori Martinez
Florian Chain
Georges Rawadi
Philippe Langella
Sandrine P. Claus
Rebeca Martin
The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
description Abstract Christensenellaceae is a family of subdominant commensal bacteria found in humans. It is thought to play an important role in gut health by maintaining microbial symbiosis. Indeed, these bacteria occur at significantly lower levels or are absent in individuals suffering from inflammatory bowel diseases (IBDs). Here, we explored if type species Christensenella minuta (strain: DSM 22607) could have the potential to help treat IBDs. We assessed key properties displayed by the bacterium using a combination of in vitro and in vivo assays. We found that while C. minuta is a strict anaerobe, it is also oxygen tolerant. Additionally, we observed that the species produces high levels of acetate and moderate levels of butyrate. We performed deep phenotyping using Biolog microarrays. Using human intestinal cell lines, we discovered that C. minuta demonstrated strong anti-inflammatory activity, resulting in reduced levels of proinflammatory IL-8 cytokines via the inhibition of the NF-κB signaling pathway. Furthermore, C. minuta protected intestinal epithelial integrity in vitro. Finally, in two distinct animal models of acute colitis, C. minuta prevented intestinal damage, reduced colonic inflammation, and promoted mucosal healing. Together, these results indicate that C. minuta has potent immunomodulatory properties, underscoring its potential use in innovative microbiome-based IBD biotherapies.
format article
author Camille Kropp
Katy Le Corf
Karima Relizani
Kevin Tambosco
Ccori Martinez
Florian Chain
Georges Rawadi
Philippe Langella
Sandrine P. Claus
Rebeca Martin
author_facet Camille Kropp
Katy Le Corf
Karima Relizani
Kevin Tambosco
Ccori Martinez
Florian Chain
Georges Rawadi
Philippe Langella
Sandrine P. Claus
Rebeca Martin
author_sort Camille Kropp
title The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
title_short The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
title_full The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
title_fullStr The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
title_full_unstemmed The Keystone commensal bacterium Christensenella minuta DSM 22607 displays anti-inflammatory properties both in vitro and in vivo
title_sort keystone commensal bacterium christensenella minuta dsm 22607 displays anti-inflammatory properties both in vitro and in vivo
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9f0a79730e0d456f87c210b29cb9337f
work_keys_str_mv AT camillekropp thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT katylecorf thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT karimarelizani thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT kevintambosco thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT ccorimartinez thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT florianchain thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT georgesrawadi thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT philippelangella thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT sandrinepclaus thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT rebecamartin thekeystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT camillekropp keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT katylecorf keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT karimarelizani keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT kevintambosco keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT ccorimartinez keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT florianchain keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT georgesrawadi keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT philippelangella keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT sandrinepclaus keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
AT rebecamartin keystonecommensalbacteriumchristensenellaminutadsm22607displaysantiinflammatorypropertiesbothinvitroandinvivo
_version_ 1718389093020205056